glp 1 receptor drugs GLP-1 agonists GLP-1 Receptor Agonist Market Size
Description
Zepbound is the same medication approved specifically for chronic weight management in adults with obesity or overweight with a weight-related condition
Nathanson D, Erdogdu O, Pernow J, Zhang Q, Nystrom T
GLP-1RA has been demonstrated to reduce the generation of inflammatory mediators by inhibiting NF-B activation
GLP-1 agonists which include semaglutide medications such as Wegovy and Ozempic are a class of medications that mimic the GLP-1 hormone to help treat diabetes and obesity
However, gastrointestinal (GI) adverse events remain the most common limitations to long-term therapy
